FDA Approvals of Aging Therapies: Status, Motivation & the Path to Eliminating Aging

CDD Vault recently hosted the first webinar in our Longevity Webinar Series featuring Dr. Karl R. Pfleger (@karlpfleger), Founder of AgingBiotech.info. During the presentation, Dr. Pfleger explored how advances in geroscience, recent FDA approvals, and continued investment are accelerating the development of therapeutics that target the biology of aging rather than individual diseases. The discussion examined how the field has evolved from an emerging area of research into a rapidly growing biotechnology sector with expanding clinical programs, increasing regulatory momentum, and a growing ecosystem of companies working to extend healthy lifespan. You can view Dr. Pfleger's presentation slides here: https://www.collaborativedrug.com/hubfs/FDA%20Approvals%20of%20Aging%20Therapies%20Have%20Started_%20The%20Motivation%20for%2c%20Status%20of%2c%20%26%20Path%20to%20Eliminating%20Aging%20(1).pdf